Identification of potent virtual leads to design novel PLK1 inhibitors: pharmacophore modelling, virtual screening and molecular docking studies

By He Lufen   Zhou Lu   Wang Taijin   Li Zicheng   Tang Xiangyang  

Molecular Simulation, Vol. 39, Iss. 8, 2013-07 ,pp. : 640-652

Taylor & Francis Ltd

Access to resources Recommend Favorite

3D QSAR pharmacophore-based virtual screening and molecular docking studies to identify novel matrix metalloproteinase 12 inhibitors

By Singh Udghosh   Gangwal Rahul P.   Prajapati Rameshwar   Dhoke Gaurao V.   Sangamwar Abhay T.  

Molecular Simulation, Vol. 39, Iss. 5, 2013-04 ,pp. : 385-396

Taylor & Francis Ltd

Access to resources Recommend Favorite

3D-QSAR studies of checkpoint kinase 1 inhibitors based on molecular docking and CoMFA

By Wang Rong Wei   Zhou Lu   Zuo Zhili   Ma Xiang   Yang Min  

Molecular Simulation, Vol. 36, Iss. 2, 2010-02 ,pp. : 87-110

Taylor & Francis Ltd

Access to resources Recommend Favorite

Molecular modelling studies on d-annulated benzazepinones as VEGF-R2 kinase inhibitors using docking and 3D-QSAR

By Lan Ping   Sun Jun-Rong   Chen Wan-Na   Sun Ping-Hua   Chen Wei-Min  

Journal of Enzyme Inhibition and Medicinal Chemistry, Vol. 26, Iss. 3, 2011-06 ,pp. : 367-377

Informa Healthcare

Access to resources Recommend Favorite

Development of 3D-pharmacophore model followed by successive virtual screening, molecular docking and ADME studies for the design of potent CCR2 antagonists for inflammation-driven diseases

By Singh Rajesh   Balupuri Anand   Sobhia M. Elizabeth  

Molecular Simulation, Vol. 39, Iss. 1, 2013-01 ,pp. : 49-58

Taylor & Francis Ltd

Access to resources Recommend Favorite